ROBERT N WILSON
CIK 1189022 · last filed 2026-06-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$21.74M
Companies
7
Total Filings
69
Lifetime Open-Market Net
$2.93M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CALC | Director | 1,604,650 | $0.72 | $1.15M | $222.4K | 9 | 2026-06-29 |
| CalciMedica, Inc. (SCPH) Delisted | Director | 417,529 | $5.67 | $2.37M | $400.8K | 3 | 2024-11-01 |
| CalciMedica, Inc. (GRAY) Delisted | Director | 181,655 | $5.50 | $999.1K | $0 | 1 | 2023-03-22 |
| SCHW | Director | 194,582 | $105.78 | $20.58M | $0 | 25 | 2018-12-14 |
| HESS CORP (HES) Delisted | Director | 79,581 | $160.40 | $12.76M | $475.0K | 13 | 2016-03-03 |
| MADRIGAL PHARMACEUTICALS, INC. (SNTA) Delisted | Director | 760,936 | — | — | $1.83M | 16 | 2015-07-06 |
| VIVUS INC (VVUS) Delisted | Director | 2,565 | — | — | $0 | 2 | 2013-08-16 |
Recent Filings · Page 4 of 7
69 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-10-03 | SCHW | Grant (A) | — | $0 | EDGAR |
| 2013-08-16 | VIVUS INC (VVUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-07-03 | MADRIGAL PHARMACEUTICALS, INC. (SNTA) Delisted | Grant (A) | +2,000 | $0 | EDGAR |
| 2013-07-03 | SCHW | Grant (A) | — | $0 | EDGAR |
| 2013-06-06 | MADRIGAL PHARMACEUTICALS, INC. (SNTA) Delisted | Buy (P) | +10,000 | $50.0K | EDGAR |
| 2013-05-22 | SCHW | Grant (A) | +3,642 | $0 | EDGAR |
| 2013-04-30 | VIVUS INC (VVUS) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
| 2013-04-03 | SCHW | Mixed | +5,080 | $7 | EDGAR |
| 2013-03-08 | HESS CORP (HES) Delisted | Mixed | +2,521 | $25.0K | EDGAR |
| 2013-01-04 | SCHW | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.